131 related articles for article (PubMed ID: 30777879)
1. MCL1 and DEDD Promote Urothelial Carcinoma Progression.
Hong AL; Guerriero JL; Doshi MB; Kynnap BD; Kim WJ; Schinzel AC; Modiste R; Schlauch AJ; Adam RM; Kwiatkowski DJ; Beroukhim R; Letai A; Rosenberg JE; Hahn WC
Mol Cancer Res; 2019 Jun; 17(6):1294-1304. PubMed ID: 30777879
[TBL] [Abstract][Full Text] [Related]
2. Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
Makboul R; Refaiy A; Abdelkawi IF; Hameed DA; Elderwy AA; Shalaby MM; Merseburger AS; Hussein MR
Pathol Res Pract; 2016 May; 212(5):385-92. PubMed ID: 26916953
[TBL] [Abstract][Full Text] [Related]
3. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
4. DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer.
Lv Q; Wang W; Xue J; Hua F; Mu R; Lin H; Yan J; Lv X; Chen X; Hu ZW
Cancer Res; 2012 Jul; 72(13):3238-50. PubMed ID: 22719072
[TBL] [Abstract][Full Text] [Related]
5. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
[TBL] [Abstract][Full Text] [Related]
6. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.
Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z
Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
Cheng J; Huang H; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
Cancer Res; 2002 Jul; 62(14):4157-63. PubMed ID: 12124355
[TBL] [Abstract][Full Text] [Related]
8. IMP3 expression in urothelial carcinomas of the urinary bladder.
Ozdemir NO; Türk NS; Düzcan E
Turk Patoloji Derg; 2011 Jan; 27(1):31-7. PubMed ID: 21469424
[TBL] [Abstract][Full Text] [Related]
9. DEDD association with cytokeratin filaments correlates with sensitivity to apoptosis.
Schutte B; Henfling M; Ramaekers FC
Apoptosis; 2006 Sep; 11(9):1561-72. PubMed ID: 16820959
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of DEDDL, a human-specific isoform of DEDD.
Huang X; Zhang M; Tang H; Ruo C; Cao X
Gene Expr; 2006; 13(3):141-53. PubMed ID: 17193921
[TBL] [Abstract][Full Text] [Related]
11. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Apr; 107(5):555-9. PubMed ID: 22961206
[TBL] [Abstract][Full Text] [Related]
12. Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
Jou YC; Wang SC; Dai YC; Chen SY; Shen CH; Lee YR; Chen LC; Liu YW
Oncol Rep; 2019 Sep; 42(3):1005-1016. PubMed ID: 31322264
[TBL] [Abstract][Full Text] [Related]
13. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Nie L; Gui Y; Cai Z
Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
[TBL] [Abstract][Full Text] [Related]
14. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
15. Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC.
Zhan Y; Hegde R; Srinivasula SM; Fernandes-Alnemri T; Alnemri ES
Cell Death Differ; 2002 Apr; 9(4):439-47. PubMed ID: 11965497
[TBL] [Abstract][Full Text] [Related]
16. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
Hour TC; Huang CY; Lin CC; Chen J; Guan JY; Lee JM; Pu YS
Anticancer Drugs; 2004 Sep; 15(8):779-85. PubMed ID: 15494640
[TBL] [Abstract][Full Text] [Related]
17. Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.
Jimenez RE; Hussain M; Bianco FJ; Vaishampayan U; Tabazcka P; Sakr WA; Pontes JE; Wood DP; Grignon DJ
Clin Cancer Res; 2001 Aug; 7(8):2440-7. PubMed ID: 11489824
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
[TBL] [Abstract][Full Text] [Related]
19. [DEDD decreases Smad3 activity, promotes tumor cell apoptosis and inhibits proliferation].
Hua F; Xue JF; Lü XX; Hu ZW
Yao Xue Xue Bao; 2013 May; 48(5):680-5. PubMed ID: 23888690
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the Molecular Mechanism Underlying the Inhibitory Efficacy of Taiwanese Local Pomegranate Peels against Urinary Bladder Urothelial Carcinoma.
Chang CP; Chan YY; Li CF; Chien LH; Lee ST; Wu TF
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29702555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
